SPRINGLEAF THERAPEUTICS
SpringLeaf Therapeutics (formerly known as Entra Pharmaceuticals, Inc.) is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.
SPRINGLEAF THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2007-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.springleaftx.com
Total Employee:
11+
Status:
Closed
Contact:
617-358-4927
Email Addresses:
[email protected]
Total Funding:
34.59 M USD
Technology used in webpage:
SPF Google Font API Amazon Amazon Virginia Region Amazon Ohio Region NameBright
Founder
Investors List
Flybridge
Flybridge investment in Series B - Springleaf Therapeutics
Excel Venture Management
Excel Venture Management investment in Series B - Springleaf Therapeutics
GSK
GSK investment in Series B - Springleaf Therapeutics
Flybridge
Flybridge investment in Series A - Springleaf Therapeutics
North Bridge Venture Partners & Growth Equity
North Bridge Venture Partners & Growth Equity investment in Series A - Springleaf Therapeutics
Flybridge
Flybridge investment in Series A - Springleaf Therapeutics
